You have 9 free searches left this month | for more free features.

Unresectable Rectal Neoplasms

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rectal Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)

Completed
  • Rectal Neoplasms
  • Irreversible electroporation (IRE)
  • NanoKnife
  • Guangzhou, Guangdong, China
    Biological treatment center in Fuda cancer hospital
Sep 1, 2021

Rectal Cancer, Recurrent Trial in Shanghai (Carbon ion radiation therapy DT: 74Gy/20 fractions)

Not yet recruiting
  • Rectal Cancer
  • Recurrent
  • Carbon ion radiation therapy DT: 74Gy/20 fractions
  • Shanghai, Pudong, China
    Shanghai Proton and Heavy ion center
Apr 7, 2023

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston (CXCR1/2

Recruiting
  • Metastatic Colon Adenocarcinoma
  • +20 more
  • CXCR1/2 Inhibitor SX-682
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,

Completed
  • Rectal Adenocarcinoma
  • +4 more
  • Quality-of-Life Assessment
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jan 3, 2023

Palliative Primary Tumor Resection in Minimally Symptomatic

Recruiting
  • Colorectal Neoplasms
  • +12 more
  • Moscow, Russian Federation
    Ryzhikh National Medical Research Center of Coloproctology
Apr 2, 2022

Advanced Colorectal Carcinoma, Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in United States

Recruiting
  • Advanced Colorectal Carcinoma
  • +26 more
  • Tampa, Florida
  • +3 more
Jun 22, 2022

Metastatic or Unresectable Colon or Rectal Cancer forCOLOMATE

Recruiting
  • Metastatic Colon Adenocarcinoma
  • +19 more
  • Genetic Testing
  • Scottsdale, Arizona
  • +17 more
Mar 2, 2022

Rectal Tumors Trial in Beijing (SCPRT plus neoadjuvant chemo, long course chemoradiation)

Recruiting
  • Rectal Neoplasms
  • SCPRT plus neoadjuvant chemotherapy
  • long course chemoradiation
  • Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Sep 1, 2021

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston

Recruiting
  • Metastatic Colon Adenocarcinoma
  • +30 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2022

Rectal Cancer Trial in Kaohsiung City (drug, procedure, radiation)

Terminated
  • Rectal Cancer
  • Kaohsiung City, Taiwan
    Kaohsiung Medical University Hospital
Dec 17, 2021

Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Newport Beach (hMN14 (labetuzumab))

Completed
  • Colorectal Cancer
  • +6 more
  • hMN14 (labetuzumab)
  • Newport Beach, California
    Hoag Cancer Center
Aug 12, 2021

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus

Active, not recruiting
  • Adult Solid Neoplasm
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Advanced Rectal Cancer, Distal Metastasis Trial in Shanghai (a combination therapy)

Not yet recruiting
  • Advanced Rectal Cancer
  • Distal Metastasis
  • a combination therapy including tislelizumab
  • Shanghai, Shanghai, China
    Xinxiang Li
Nov 12, 2022

Colon Cancer, Rectal Cancer Trial in New York (Floxuridine, Oxaliplatin, CPT-11)

Completed
  • Colon Cancer
  • Rectal Cancer
  • Floxuridine, Oxaliplatin, CPT-11
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 29, 2021

Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8 Trial in United States

Recruiting
  • Metastatic Colon Adenocarcinoma
  • +7 more
  • Cetuximab
  • +2 more
  • Bloomington, Illinois
  • +70 more
Aug 6, 2022

Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1 Trial in Changchun (nCRT ? (CapeOX+Sintilimab)×6 ?

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • +2 more
  • nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W
  • Changchun, Ji Lin, China
    First Hospital of Jilin University
Aug 11, 2023

FAPI in Rectal Cancer TNT

Not yet recruiting
  • Rectal Neoplasms Malignant
  • Ga-68 FAPI
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Nov 27, 2023

Gallbladder Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)

Completed
  • Gallbladder Neoplasms
  • Irreversible electroporation (IRE)
  • NanoKnife
  • Guangzhou, Guangdong, China
    Biological treatment center in Fuda cancer hospital
Sep 1, 2021

Laryngeal Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)

Completed
  • Laryngeal Neoplasms
  • Irreversible electroporation (IRE)
  • NanoKnife
  • Guangzhou, Guangdong, China
    Biological treatment center in Fuda cancer hospital
Sep 1, 2021

Rectal Tumors Trial (Registry study, no specific intervention)

Not yet recruiting
  • Rectal Neoplasms
  • Registry study, no specific intervention
  • (no location specified)
May 21, 2023

Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)

Recruiting
  • Rectal Neoplasms
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Aug 27, 2023

MRI T1 Relaxation Time in Rectal Cancer

Recruiting
  • Rectal Cancer
  • Locally Advanced Rectal Carcinoma
    • Vejle, Jylland, Denmark
      Vejle Hospital
    May 16, 2023

    Rectal Cancer Trial in Hamburg (Surgery)

    Completed
    • Rectal Cancer
    • Surgery
    • Hamburg, Germany
      University of Hamburg Medical Institutions
    Nov 1, 2023